INTENT TO SOLE SOURCE Wolters Kluwer VitalLaw Platform Subscription FDA – 75F40126Q00066
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The FDA / Office of the Commissioner (OC) / Office of the Chief Counsel (OCC) has issued an Intent to Sole Source for the renewal of its Wolters Kluwer VitalLaw Platform subscription. This requirement is for a one-year base period with four one-year options, providing critical legal research support. Interested parties who believe they can meet the requirement may submit a capability statement.
Scope of Work
This opportunity is for the renewal of a subscription to the Wolters Kluwer VitalLaw Platform, which offers comprehensive legal research support. Key deliverables include access to proprietary treatises, explanatory content, case reporters, and government documents. Specific libraries covered are:
- Administrative Law Treatise
- Food, Drug & Cosmetic Law Library (including the Food, Drug, and Cosmetic Law Reporter)
- Generic & Innovator Drugs Library
- Medical Devices Library (including the Medical Devices Reporter) The platform also provides access to FDA Warning Letters, Compliance Policy Guides, statutes, regulations, and newsletters, along with unlimited IDs for FDA attorneys and staff, 24/7 access, and customer support.
Contract & Timeline
- Type: Intent to Sole Source (Special Notice), Firm Fixed-Price Purchase Order
- Authority: FAR 6.302-1, Only One Responsible Source
- Period of Performance: One-year base with four one-year options
- Place of Performance: Silver Spring, MD 20993, United States
- Published Date: February 13, 2026
- Response Due: February 24, 2026, 1:00 PM EST
Set-Aside & Eligibility
This is a Sole Source procurement, citing FAR 6.302-1. The government believes CCH Incorporated is the only source capable of providing the required mission-critical legal research content subscription service.
Submission & Evaluation
This notice is an intent to award and not a request for competitive proposals. However, interested parties who believe they can provide the required services may submit a capability statement. A determination not to compete will be made based on responses received.
Contact Information
Primary Point of Contact: Terina Hicks (terina.hicks@fda.hhs.gov). No telephonic inquiries will be accepted.